Long-acting HIV shots and teen clubs for adolescents
Part of Immune system & allergy, Infections clinical trials.
This study tests whether a long-acting injectable HIV medicine (given every couple of months) and teen support clubs can help adolescents stay healthy and engaged in care. If you are a teen living with HIV, this trial may offer a more convenient treatment option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 12 and 19 years old.
- You have HIV and know your status.
- You have been taking HIV medicine for at least 6 months.
- You can read and speak one of these languages: English, isiZulu, Sepedi, Afrikaans, Xhosa, or Sesotho.
- You are willing to give consent (and have a parent or guardian agree) to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests ways to help young people in Uganda prevent HIV or stay healthy if they already have HIV. It offers free prevention pills or injections and care for those living with HIV.
This study looks at whether offering private, confidential HIV tests to teenagers during regular checkups increases the number of teens who get tested. Participating clinics will offer this service, and researchers will track how many teens get tested.
This study tests whether getting HIV care through a community program is as helpful as going to a clinic for people who just found out they have HIV. It looks at how well they stay in care and take their medicine.
This study tests a counseling program for teens with HIV who have had suicidal thoughts or behaviors. The goal is to see if the program is helpful and can be offered at local clinics.
This trial tests a new combination of HIV medicines for children and teenagers under 18 who weigh at least 35 kilograms (about 77 pounds). It aims to see if this treatment is safe and effective for young people who have not been treated before or who are already on a stable HIV treatment.
This trial studies whether a child can safely move from HIV medicine taken by mouth to long-acting monthly injections. It looks at keeping HIV levels suppressed (very low) and monitoring side effects and safety over time.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.